About this Research Topic
Furthermore, therapeutic approaches to Chronic Urticaria (CU) represent a challenging field as no curative treatment exists for CU, and all currently recommended treatment options are intended to control and prevent the symptoms of CU. The ultimate goal remains the development of treatments that can prevent CU, alter its course, and cure patients. Furthermore the trials of new therapeutic agents, both biologicals and small molecules provide new knowledge in distinct areas of underlying mechanisms and further elucidate pathogenic pathways.
The goals are to provide state-of the art information (either investigational and clinical research or review articles) that cover the following fields of the topic: acute urticaria, pathogenic mechanisms of CU’s, burden of CSU and inducible CUs, quality of life in CU patients, new treatments, biomarkers, therapeutic approaches, and unmet needs. Novelty and uniqueness are the main goals; urticaria experts as well as to non-specialists are both appreciated if they address a certain goal or test a well-defined hypothesis.
Keywords: Biomarkers, Mechanisms, Treatment, Endotypes, Autoimmune, Urticaria, urticaria
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.